UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is a heterogeneous group of hematological tumors composed of distinct subtypes that vary in their genetic abnormalities, gene expression signatures, and prognoses. However, it remains unclear whether T-ALL subtypes differ at the functional level, and, as s...

Descripción completa

Detalles Bibliográficos
Autores principales: Benyoucef, Aissa, Palii, Carmen G., Wang, Chaochen, Porter, Christopher J., Chu, Alphonse, Dai, Fengtao, Tremblay, Véronique, Rakopoulos, Patricia, Singh, Kulwant, Huang, Suming, Pflumio, Francoise, Hébert, Josée, Couture, Jean-Francois, Perkins, Theodore J., Ge, Kai, Dilworth, F. Jeffrey, Brand, Marjorie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782046/
https://www.ncbi.nlm.nih.gov/pubmed/26944678
http://dx.doi.org/10.1101/gad.276790.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782046/
https://www.ncbi.nlm.nih.gov/pubmed/26944678
http://dx.doi.org/10.1101/gad.276790.115

Ejemplares similares